A model framework for projecting the prevalence and impact of Long-COVID in the UK

Author:

Martin ChrisORCID,Luteijn MichielORCID,Letton WilliamORCID,Robertson Josephine,McDonald StuartORCID

Abstract

AbstractBackgroundThe objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 in the UK population, including symptoms of ‘long-COVID’. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long COVID.MethodsThe prevalence of symptomatic COVID-19, encompassing acute symptoms and long-COVID symptoms, was modelled using a decay function. Permanent injury as a result of COVID-19 infection, was modelled as a fixed prevalence. Both parts are combined to calculate QALY loss due to COVID-19 symptoms.ResultsAssuming a 60% final attack rate for SARS-CoV-2 infection in the population, we modelled 299,719 QALYs lost within 1 year of infection (90% due to symptomatic COVID-19 and 10% permanent injury) and 557,754 QALYs lost within 10 years of infection (49% due to symptomatic COVID-19 and 51% due to permanent injury). The UK Government willingness-to-pay to avoid these QALY losses would be £17.9 billion and £32.2 billion, respectively. Additionally, 90,143 people were subject to permanent injury from COVID-19 (0.14% of the population).ConclusionGiven the ongoing development in information in this area, we present a model framework for calculating the health economic impacts of symptoms following SARS-CoV-2 infection. This model framework can aid in quantifying the adverse health impact of COVID-19, long COVID and permanent injury following COVID-19 in society and assist the proactive management of risk posed to health. Further research is needed using standardised measures of patient reported outcomes relevant to long COVID and applied at a population level.

Publisher

Cold Spring Harbor Laboratory

Reference33 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

2. World Health Organization. Coronavirus disease (COVID-19) pandemic [Internet]. 2021 [cited 2021 Apr 24]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

3. GOV. UK Coronavirus (COVID-19) in the UK [Internet]. 2020 [cited 2020 Dec 22]. Available from: https://coronavirus.data.gov.uk/

4. NICE, SIGN, RCGP. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London, Edinburgh; 2020.

5. Arnold DT , Hamilton FW , Milne A , Morley AJ , Viner J , Attwood M , et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax [Internet]. 2020 Dec 3;thoraxjnl-2020-216086. Available from: https://thorax.bmj.com/lookup/doi/10.1136/thoraxjnl-2020-216086

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3